Scope of Consolidation - Additional Information (Details) - EUR (€) |
2 Months Ended | 12 Months Ended | |
---|---|---|---|
Dec. 31, 2023 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
Disclosure of subsidiaries [line items] | |||
Consideration adjustment parties within acquisition closing day | 110 days | ||
Perugini S.r.l. | |||
Disclosure of subsidiaries [line items] | |||
Revenue | € 54,300 | ||
Profit | € 900 | ||
Medical Glass a.s. | |||
Disclosure of subsidiaries [line items] | |||
Percentage equity interest in subsidiary | 99.74% | 99.74% |
X | ||||||||||
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. No definition available.
|
X | ||||||||||
- Definition The profit (loss) of the acquiree, since the acquisition date, included in the consolidated statement of comprehensive income. [Refer: Profit (loss)] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of revenue of the acquiree since the acquisition date included in the consolidated statement of comprehensive income. [Refer: Revenue] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Consideration adjustment parties within acquisition closing day. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|